H. Jeffrey Wilkins
2021
In 2021, H. Jeffrey Wilkins earned a total compensation of $1.2M as Former Chief Medical Officer at Avalo Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $165,580 |
---|---|
Option Awards | $659,405 |
Salary | $425,000 |
Total | $1,249,985 |
Wilkins received $659.4K in option awards, accounting for 53% of the total pay in 2021.
Wilkins also received $165.6K in non-equity incentive plan and $425K in salary.
Rankings
In 2021, H. Jeffrey Wilkins' compensation ranked 7,974th out of 12,415 executives tracked by ExecPay. In other words, Wilkins earned more than 35.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,974 | 36th |
Manufacturing | 3,522 | 36th |
Chemicals And Allied Products | 1,565 | 34th |
Drugs | 1,390 | 34th |
Pharmaceutical Preparations | 1,031 | 33rd |
Wilkins' colleagues
We found four more compensation records of executives who worked with H. Jeffrey Wilkins at Avalo Therapeutics in 2021.